Perrigo Company plc (NYSE: PRGO) is listed among the Best Stocks for a Dividend Achievers List. JPMorgan recently lowered its price target on PRGO to $18 from $20, maintaining a Neutral rating. For Q3 2025, PRGO reported a 4.06% revenue decline to $1.04 billion. President and CEO Patrick Lockwood-Taylor noted soft OTC consumption but strong in-market results. Additionally, PRGO announced a strategic review of its infant formula business on November 5, aiming for higher-margin branded products. Operating globally for over 100 years, PRGO focuses on health and wellness products in North America and Europe.

Read more at Yahoo Finance: Perrigo (PRGO) Target Reduced as JPMorgan Refreshes Estimates